Reports for SANDOZ CANADA INCORPORATED

Company Name

SANDOZ CANADA INCORPORATED

Totals

Shortage reports

2123

Actual shortage: 50 (2%)
Anticipated shortage: 9 (0%)
Avoided shortage: 19 (1%)
Resolved: 2045 (96%)

Discontinuation Reports

101

To be discontinued: 1 (1%)
Discontinued: 98 (97%)
Reversed: 2 (2%)

Late reports

444 (20%)

Overdue reports

38 (63%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
SANDOZ AMLODIPINE 5MG TABLET Resolved 2023-04-18 2023-05-03 189788
SANDOZ AMLODIPINE 10MG TABLET Resolved 2023-04-21 2023-05-16 190126
SANDOZ AMLODIPINE 5MG TABLET Resolved 2023-04-21 2023-05-03 190130
SANDOZ AMLODIPINE 10MG TABLET Resolved 2023-05-01 2023-05-25 191369
SANDOZ AMLODIPINE 10MG TABLET Resolved 2021-05-26 2021-06-14 139887
SANDOZ AMOXI-CLAV TABLET 125MG 500MG TABLET Resolved 2023-06-05 2023-06-13 193693
SANDOZ AMOXI-CLAV TABLET 125MG 875MG TABLET Resolved 2023-11-20 2023-12-12 210829
SANDOZ AMOXI-CLAV TABLET 125MG 875MG TABLET Resolved 2024-01-23 2024-02-06 217029
SANDOZ AMOXI-CLAV TABLET 125MG 875MG TABLET Resolved 2024-02-12 2024-04-04 219213
SANDOZ AMOXI-CLAV TABLET 125MG 500MG TABLET Resolved 2024-09-16 2025-01-28 237732
SANDOZ AMPHETAMINE XR 25MG CAPSULE (EXTENDED RELEASE) Resolved 2024-07-02 2024-08-06 231741
SANDOZ AMPHETAMINE XR 10MG CAPSULE (EXTENDED RELEASE) Resolved 2024-08-05 2024-08-28 234467
SANDOZ AMPHETAMINE XR 5MG CAPSULE (EXTENDED RELEASE) Resolved 2024-11-11 2024-11-19 242743
SANDOZ AMPHETAMINE XR 10MG CAPSULE (EXTENDED RELEASE) Resolved 2023-06-27 2023-08-08 196662
SANDOZ AMPHETAMINE XR 20MG CAPSULE (EXTENDED RELEASE) Resolved 2023-07-24 2023-08-08 199806
SANDOZ AMPHETAMINE XR 10MG CAPSULE (EXTENDED RELEASE) Resolved 2023-10-02 2023-11-07 205782
SANDOZ AMPHETAMINE XR 20MG CAPSULE (EXTENDED RELEASE) Resolved 2023-10-10 2023-10-24 206684
SANDOZ AMPHETAMINE XR 25MG CAPSULE (EXTENDED RELEASE) Resolved 2023-11-20 2024-01-03 210832
SANDOZ AMPHETAMINE XR 15MG CAPSULE (EXTENDED RELEASE) Resolved 2021-07-19 2021-08-03 142705
SANDOZ AMPHETAMINE XR 10MG CAPSULE (EXTENDED RELEASE) Resolved 2021-08-09 2021-08-23 143847

Showing 561 to 580 of 2123

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ALFENTANIL INJECTION USP Discontinued 2019-10-15 2019-10-15 96610
ATRACURIUM BESYLATE INJECTION Discontinued 2019-10-15 2019-10-15 96613
BETAJECT Discontinued 2019-10-15 2019-10-15 96616
BLUE COLLYRIUM Discontinued 2019-10-15 2019-10-15 96619
BRETYLIUM TOSYLATE INJECTION USP Discontinued 2020-04-01 2020-04-01 110288
BRETYLIUM TOSYLATE INJECTION USP 50MG SOLUTION Discontinued 2017-12-06 2017-12-06 31958
CLINDAMYCIN INJECTION USP 150MG LIQUID Discontinued 2017-06-06 2017-10-18 12122
CODEINE PHOSPHATE INJECTION USP 30MG LIQUID Discontinued 2022-04-20 2022-04-20 159064
COMTAN 200MG TABLET Discontinued 2022-03-03 2022-03-04 155940
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Discontinued 2018-08-27 2019-01-02 59179
FOLIC ACID INJECTION USP 5MG LIQUID To be discontinued 2019-05-01 2019-05-01 82956
FOLIC ACID INJECTION USP 5MG LIQUID Discontinued 2020-01-28 2020-01-28 104481
HEPARIN SODIUM INJECTION USP (SINGLE USE VIAL-PRESERVATIVE FREE) 10000UNIT SOLUTION Discontinued 2018-07-04 2018-07-31 54349
HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE) 10000UNIT SOLUTION Discontinued 2024-05-17 2024-05-18 228249
HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE) 10000UNIT SOLUTION Discontinued 2023-10-18 2023-10-19 207275
IMIPENEM AND CILASTATIN FOR INJECTION USP 250MG 250MG POWDER FOR SOLUTION Discontinued 2021-08-23 2021-08-23 144467
LORAZEPAM INJECTION USP 2MG SOLUTION Discontinued 2020-02-14 2020-03-12 106265
MICRO PLUS 6 (CONCENTRATE) 75MCG 60MCG 10MCG 0.5MG 1MG 5MG LIQUID Discontinued 2021-10-25 2021-10-26 147927
MILRINONE LACTATE INJECTION 1MG SOLUTION Discontinued 2022-06-17 2022-06-18 163000
OLANZAPINE FOR INJECTION 10MG POWDER FOR SOLUTION Discontinued 2020-06-22 2020-06-22 118553

Showing 1 to 20 of 101